PLMI Blog

Hormones are the body’s master regulators, orchestrating metabolism, immunity, mood, and cognition. The menstrual cycle—recognized as the “fifth vital sign” (1–3)—offers a dynamic and accessible window into hormonal health. Subtle shifts in cycle length, ovulation, or luteal hormone production can manifest as cramps, bloating, migraines, mood swings, or fatigue, often reflecting deeper metabolic, endocrine, or immune imbalances.

Hormone monitoring transforms these fluctuations from unpredictable challenges into actionable insights. By tracking hormonal rhythms across the cycle, individuals gain a real-time understanding of their physiology, allowing targeted strategies to reduce symptom burden, restore balance, and build resilience. Monitoring positions women to not only respond to symptoms but also anticipate and prevent them, turning the menstrual cycle into a proactive tool for health.

Hormones as a Vital Sign

Hormones function as the body’s hidden vital sign, coordinating reproductive, metabolic, immune, and neurologic systems in constant dialogue. Even subtle changes in cycle dynamics—shortened or lengthened phases, anovulatory cycles, or luteal insufficiency—can indicate systemic stressors such as metabolic imbalance, inflammation, or HPA axis dysregulation. Objective hormone monitoring converts these subtle variations into measurable signals, enabling early recognition of deviations and phase-specific interventions. This approach shifts care from reactive symptom management to personalized, precision-guided strategies supporting hormonal balance, resilience, and quality of life.

Advancements in Hormone Monitoring

Recent innovations have made the menstrual cycle a measurable and actionable biomarker. The Quantum Menstrual Health Monitoring Study validated a home-based urine hormone device measuring FSH, estrone-3-glucuronide (E1G), LH, and pregnanediol glucuronide (PdG), demonstrating accurate tracking of both regular and irregular cycles, including those disrupted by PCOS or exercise-induced dysfunction, and revealing contributors to pain, irregular bleeding, and fatigue without invasive testing (4). Daily urinary LH and PdG tracking has been shown to identify cycle phase and day with 95% accuracy (5), enabling detection of subtle variations that correlate with related symptoms, including estrogen-driven headaches or luteal-phase mood fluctuations.

Complementary work established robust serum reference ranges for estradiol, LH, and progesterone, reinforcing the reliability of both laboratory-based and at-home monitoring systems (6). Together, these advancements provide actionable, real-time data, allowing women and their clinicians to move beyond symptom management toward interventions that restore rhythm, reduce burden, and optimize reproductive and systemic health.

Detecting Ovulatory and Postpartum Health

Ovulation is central not only to fertility but also to systemic well-being. Comprehensive cycle mapping and ovulation tracking improve fertility outcomes, shorten time to conception, and identify luteal phase insufficiencies contributing to PMS, migraines, and abnormal bleeding (6). Standard predictor kits or apps may miss these nuances, whereas advanced hormone monitors confirm sustained progesterone production, providing insight into symptom patterns that might otherwise remain hidden.

Confirmation of ovulation and luteal adequacy enables precisely timed fertility strategies, luteal support, and cycle-aware nutrition approaches, improving conception success and alleviating premenstrual symptoms. Bouchard et al. (2023) extended these findings to postpartum women, demonstrating that quantitative hormone monitors detect nuanced return-to-fertility patterns, including minimal ovarian activity, anovulatory follicles, or early ovulation (4). This empowers women with knowledge of their reproductive health and allows clinicians to guide postpartum recovery, symptom management, and family planning more effectively.

Supporting Symptom-Prone Transitions

Perimenopause presents unique challenges, with fluctuating estrogen and progesterone often driving heavy bleeding, hot flashes, sleep disruption, and mood swings. Meyers et al. (2023) applied quantitative hormone monitoring in women aged 40–50, revealing distinct perimenopausal hormone patterns that help differentiate natural transitions from pathology (7). This precision enables women and clinicians to align nutrition, stress-regulation practices, and evidence-based botanicals with each individual’s hormonal rhythm, reducing symptom burden while promoting resilience through the menopausal transition.

Self-Knowledge & Empowerment

Digital tools are transforming engagement with menstrual health, moving beyond basic symptom tracking to enhance knowledge, self-efficacy, and proactive health management. Period tracking apps, initially designed for fertility, now support energy, mood, and lifestyle optimization (8). A 2025 longitudinal study of the Flo Cycle Tracking App, involving over 6,000 women across 52 countries, demonstrated that app access significantly improved awareness of reproductive cues and quality of life, while reducing menstrual-related disruption (9). Many of these benefits were mediated by improved menstrual health knowledge, highlighting that understanding one’s cycle directly supports well-being.

Complementing these findings, Stujenske et al. (2023) reported that women with PCOS, endometriosis, and infertility found cycle tracking improved both clinical diagnosis and personal self-knowledge (10-11). Wearable devices that measure basal body temperature, heart rate variability, and respiration further enhance insight into fertile windows and cycle phases, allowing women to interpret hormonal fluctuations in real-time (12).  Integrating apps and wearables strengthens self-awareness, facilitates early recognition of hormonal dysregulation, and guides lifestyle and nutrition adjustments tailored to each phase, empowering women to engage proactively with their health.

CLINICAL IMPLICATIONS: IMPROVING MENSTRUAL SYMPTOMS THROUGH MONITORING

Mood & Cognition

Monitoring luteal progesterone provides insight into both reproductive and neuropsychiatric health. Progesterone metabolites, particularly allopregnanolone, modulate GABA receptor activity, supporting anxiolysis, mood stabilization, and sleep regulation. Low or unstable luteal progesterone reduces allopregnanolone signaling, increasing susceptibility to anxiety, irritability, sleep disruption, and mood disturbances observed in PMDD (13).

During perimenopause, fluctuating progesterone and estrogen similarly affect HPA axis regulation, increasing vulnerability to first-onset mood disorders (14). Tracking luteal hormone patterns enables women to identify periods of increased risk and implement targeted, evidence-informed strategies, such as timed progesterone support and stress-modulation techniques, to balance mood and improve sleep quality. Research demonstrates that cycle tracking can reduce PMDD and PMS symptom severity, including anxiety, irritability, and sleep disturbances (8).

Inflammation & Pain

Hormonal fluctuations across the cycle profoundly influence menstrual pain and inflammatory responses. Estradiol withdrawal can sensitize trigeminal pathways, contributing to menstrual migraines, while imbalanced estrogen-to-progesterone ratios may exacerbate systemic inflammation, intensifying dysmenorrhea (15). Cortisol rhythms, regulated via the HPA axis, also modulate inflammatory and pain responses; disruptions can heighten sensitivity to menstrual discomfort.

By monitoring their hormonal patterns, women can identify phases of heightened inflammation and implement phase-specific strategies—including an anti-inflammatory diet rich in omega-3s, leafy greens, and berries, as well as magnesium supplementation and restorative movement or yoga—to reduce cramps, pain, and migraine frequency while mitigating systemic inflammatory load. Probiotic interventions in endometriosis further illustrate how awareness of hormonal patterns can guide targeted approaches to symptom management (16).

Metabolism & Energy

Hormonal fluctuations influence energy metabolism and insulin sensitivity. During the follicular phase, rising estrogen enhances insulin sensitivity and supports efficient energy utilization, contributing to higher energy availability and improved recovery. In the luteal phase, progesterone dominance modestly reduces insulin sensitivity and shifts substrate utilization toward fat oxidation, which may manifest as mid-cycle fatigue, cravings, or appetite changes (17).

Cycle-synced nutrition—such as higher complex carbohydrates in the follicular phase and balanced protein/fat intake in the luteal phase—supports stable glucose regulation, sustains energy, and enhances metabolic function. Emerging evidence highlights that reproductive hormones, including progesterone and estrogen, interact bidirectionally with the gut microbiome, influencing microbial composition and activity, which in turn can affect metabolism and hormone-related symptom expression across the menstrual cycle (18). Maintaining gut health may therefore further optimize cycle-related metabolic and neuroendocrine balance.

Fertility & Reproductive Health

Ovulation and adequate luteal-phase progesterone are essential for reproductive function. Insufficient progesterone can shorten the luteal phase, impair endometrial receptivity, and contribute to PMS or unexplained infertility. Monitoring mid-cycle LH surges and luteal progesterone patterns confirms ovulation and detects luteal insufficiency. This information guides timed interventions, including luteal-phase progesterone supplementation, cycle-aware nutrition, and fertility planning, supporting conception, reducing symptom burden, and addressing systemic effects of hormonal dysregulation (17).

Perimenopause

Quantitative hormone monitoring in women in their 40s reveals individualized estrogen and progesterone patterns, helping distinguish normal perimenopausal variability from abnormal bleeding or endocrine pathology (19). These insights support interventions to reduce symptom burden, such as phytoestrogens to support estrogenic activity, stress-mitigating strategies for HPA axis stabilization, movement to maintain metabolic and musculoskeletal health, and iron monitoring to prevent anemia from heavy bleeding. Understanding each woman’s hormonal trajectory allows care to be personalized, enhancing both reproductive and systemic resilience.

Postpartum

Following childbirth, hormonal regulation is highly dynamic. Variable progesterone production and low ovarian activity influence mood, energy, and return-to-fertility timing. Quantitative hormone monitoring clarifies ovulatory patterns, identifies early or delayed cycle resumption, and reduces anxiety surrounding fertility (20). These insights can inform nutritional support, guide fertility planning, and optimize symptom management, supporting recovery, reproductive function, and overall neuroendocrine health. Adequate iron and omega-3 intake, combined with education on cycle tracking, further enhances recovery and postpartum resilience.

Mind-Body Attunement

Menstrual health is deeply interconnected with mind-body awareness. Subtle physiological cues—such as basal body temperature, cervical fluid changes, shifts in energy, and digestion—reflect real-time hormonal transitions. Monitoring these alongside wearable and app-based data allows women to attune to internal rhythms and anticipate cycle-related changes. Stress and HPA axis activation influence estrogen and progesterone signaling through cortisol fluctuations, impacting reproductive, inflammatory, and metabolic function (21).

By cultivating awareness of these internal cues and integrating cycle-tracking insights, women can implement targeted strategies—restorative movement, adaptive stress management, and nutrition—to support neuroendocrine balance, optimize metabolic function, and modulate inflammation.

Transforming Health Through Awareness

Tracking hormones across the menstrual cycle allows individuals to monitor fertility, digestion, mood, energy, libido, and sleep, enhancing awareness of hormonal fluctuations and bodily signals (4–5). Aligning daily behaviors with cycle phases can reduce symptom burden, stabilize energy and mood, and improve overall well-being, empowering women to engage proactively with their hormonal health.

Observing the rise and fall of estrogen, progesterone, and luteinizing hormone enables personalized, phase-specific strategies that meaningfully reduce menstrual symptoms. Awareness of hormonal patterns can guide anti-inflammatory approaches and restorative movement during menstruation to ease cramps, pain, and migraines. Luteal-phase progesterone tracking identifies periods of increased vulnerability to mood fluctuations and sleep disturbances, supporting timed progesterone interventions and stress-modulation strategies to stabilize mood and improve sleep quality (13–14). Follicular-phase estrogen tracking informs nutrition and exercise adjustments to optimize energy, recovery, and metabolic function. Mid-cycle LH and progesterone monitoring supports ovulatory health, fertility planning, and cycle-aware nutritional strategies, reducing PMS severity and enhancing reproductive outcomes (4–6).

Ultimately, hormone monitoring transforms the menstrual cycle into an informative guide, helping women anticipate changes, manage symptoms, and support overall health and resilience.

Join us for our webinar, Modernizing Menstrual Health: Clinical Research, Precision Hormone Tracking & Validated Patient Outcomes, on September 30th from 5-7 PM, where speakers Jeffrey Bland, PhD, Dr. Thomas Bouchard, Alisa Vitti, and Rosemary MacKenzie will cover how hormone monitoring can personalize and inform treatment, enhancing patient engagement and outcomes.

References:

1. Committee Opinion Menstruation in Girls and Adolescents Using the Menstrual Cycle as a Vital Sign (Committee Opinion #651) Gynecol. 2015;126:1328. doi: 10.1097/aog.0000000000001210. [DOI] [PubMed] [Google Scholar]
2. Vigil P., Blackwell L.F., Cortés M.E. The Importance of Fertility Awareness in the Assessment of a Woman’s Health A Review. Linacre Q. 2013;79:426–450. doi: 10.1179/002436312804827109. [DOI] [PMC free article] [PubMed] [Google Scholar]
3. Mihm M., Gangooly S., Muttukrishna S. The normal menstrual cycle in women. Reprod. Sci. 2011;124:229–236. doi: 10.1016/j.anireprosci.2010.08.030. [DOI] [PubMed] [Google Scholar]
4. Bouchard T, Yong P, Doyle-Baker P. Establishing a Gold Standard for Quantitative Menstrual Cycle Monitoring. Medicina (Kaunas). 2023 Aug 23;59(9):1513. doi: 10.3390/medicina59091513. PMID: 37763632; PMCID: PMC10533176:
5. Hills E, Woodland MB, Divaraniya A. Using Hormone Data and Age to Pinpoint Cycle Day within the Menstrual Cycle. Medicina (Kaunas). 2023 Jul 23;59(7):1348. doi: 10.3390/medicina59071348. PMID: 37512159; PMCID: PMC10384168.::
6. Anckaert E, Jank A, Petzold J, Rohsmann F, Paris R, Renggli M, Schönfeld K, Schiettecatte J, Kriner M. Extensive monitoring of the natural menstrual cycle using the serum biomarkers estradiol, luteinizing hormone and progesterone. Pract Lab Med. 2021 Mar 13;25:e00211. doi: 10.1016/j.plabm.2021.e00211. PMID: 33869706; PMCID: PMC8042396.
7. Meyers M, Fehring RJ, Schneider M. Case Reports from Women Using a Quantitative Hormone Monitor to Track the Perimenopause Transition. Medicina (Kaunas). 2023 Sep 28;59(10):1743. doi: 10.3390/medicina59101743. PMID: 37893460; PMCID: PMC10608103
8. Ford A, De Togni G, Miller L. Hormonal Health: Period Tracking Apps, Wellness, and Self-Management in the Era of Surveillance Capitalism. Engag Sci Technol Soc. 2021 Oct 5;7(1):48-66. doi: 10.17351/ests2021.655. PMID: 37155428; PMCID: PMC7614476.
9. Goddard FGB, Prentice C, Cunningham AC, Ballard AM, Zhaunova L. Impact of the Flo Cycle Tracking App on menstrual knowledge and health in low-income and middle-income countries: a longitudinal study. BMJ Public Healt 2025 Aug 19;3(2):e002822. doi: 10.1136/bmjph-2025-002822. PMID: 40842716; PMCID: PMC12366617.
10. Schantz JS, Fernandez CSP, Anne Marie ZJ. Menstrual Cycle Tracking Applications and the Potential for Epidemiological Research: A Comprehensive Review of the Literature. Curr Epidemiol Rep. 2021 Mar;8(1):9-19. doi: 10.1007/s40471-020-00260-3. Epub 2021 Feb 20. PMID: 34055569; PMCID: PMC8162175.
11. Stujenske TM, Mu Q, Pérez Capotosto M, Bouchard TP. Survey Analysis of Quantitative and Qualitative Menstrual Cycle Tracking Technologies. Medicina (Kaunas). 2023 Aug 22;59(9):1509. doi: 10.3390/medicina59091509. PMID: 37763628; PMCID: PMC10534579.
12. Lyzwinski L, Elgendi M, Menon C. Innovative Approaches to Menstruation and Fertility Tracking Using Wearable Reproductive Health Technology: Systematic Review. J Med Internet Res. 2024 Feb 15;26:e45139. doi: 10.2196/45139. PMID: 38358798; PMCID: PMC1090533
13. Standeven LR, McEvoy KO, Osborne LM. Progesterone, reproduction, and psychiatric illness. Best Pract Res Clin Obstet Gynaecol. 2020 Nov;69:108-126. doi: 10.1016/j.bpobgyn.2020.06.001. Epub 2020 Jun 18. PMID: 32723604; PMCID: PMC8011861.
14. Musial N, Ali Z, Grbevski J, Veerakumar A, Sharma P. Perimenopause and First-Onset Mood Disorders: A Closer Look. Focus (Am Psychiatr Publ). 2021 Jul;19(3):330-337. doi: 10.1176/appi.focus.20200041. Epub 2021 Jul 9. PMID: 34690602; PMCID: PMC8475932.
15. Raffaelli B, Do TP, Chaudhry BA, Ashina M, Amin FM, Ashina H. Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence. J Headache Pain. 2023 Sep 21;24(1):131. doi: 10.1186/s10194-023-01664-4. PMID: 37730536; PMCID: PMC10512516.
16. Wegrzynowicz AK, Eyvazzadeh A, Beckley A. Current Ovulation and Luteal Phase Tracking Methods and Technologies for Fertility and Family Planning: A Review. Semin Reprod Med. 2024 Jun;42(2):100-111. doi: 10.1055/s-0044-1791190. Epub 2024 Sep 20. PMID: 39303740; PMCID: PMC11837971.
17. MacGregor KA, Gallagher IJ, Moran CN. Relationship Between Insulin Sensitivity and Menstrual Cycle Is Modified by BMI, Fitness, and Physical Activity in NHANES. J Clin Endocrinol Metab. 2021 Sep 27;106(10):2979-2990. doi: 10.1210/clinem/dgab415. PMID: 34111293; PMCID: PMC8475204.
18. Hussain T, Murtaza G, Kalhoro DH, Kalhoro MS, Metwally E, Chughtai MI, Mazhar MU, Khan SA. Relationship between gut microbiota and host-metabolism: Emphasis on hormones related to reproductive function. Anim Nutr. 2021 Mar;7(1):1-10. doi: 10.1016/j.aninu.2020.11.005. Epub 2021 Jan 4. PMID: 33997325; PMCID: PMC8110851.
19. Meyers M, Fehring RJ, Schneider M. Case Reports from Women Using a Quantitative Hormone Monitor to Track the Perimenopause Transition. Medicina (Kaunas). 2023 Sep 28;59(10):1743. doi: 10.3390/medicina59101743. PMID: 37893460; PMCID: PMC10608103.
20. Bouchard TP, Schweinsberg K, Smith A, Schneider M. Using Quantitative Hormone Monitoring to Identify the Postpartum Return of Fertility. Medicina (Kaunas). 2023 Nov 15;59(11):2008. doi: 10.3390/medicina59112008. PMID: 38004057; PMCID: PMC10672941.
21. Sukhareva EV. The role of the corticotropin-releasing hormone and its receptors in the regulation of stress response. Vavilovskii Zhurnal Genet Selektsii. 2021 Mar;25(2):216-223. doi: 10.18699/VJ21.025. PMID: 34901719; PMCID: PMC8627883.